The aim of this study was to comparatively analyze the predictive impact of sequential MRD monitoring with leukemia‐associated immunophenotypes (LAIP)‐MFC and WT1 Q‐PCR in a cohort of 104 consecutively treated AML patients. This evidence concerns the gene WT1 and acute myeloid leukemia.